Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor

Annals of Diagnostic Pathology

Volumn 13, Issue 2, 2009, Pages 82-88

  Tena Suck, Martha Lilia ^a   Ortiz Plata, Alma ^a   Galán, Francisco ^b   Sánchez, Aurora ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Hospital Medica Sur   (Mexico)

Author keywords

Adamantinomatous craniopharyngioma; Brain tumor; Epithelial cell adhesion molecule (Ep CAM); Immunohistochemistry; Pituitary tumor transforming gene (PTTG 1)

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; SECURIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; STELLATE CELL; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CRANIOPHARYNGIOMA; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 62149137724     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2008.12.004     Document Type: Article

References (29)

1. Van Effenterre R., and Boch A.L. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97 (2002) 3-11
2. Weiner H.L., Wisoff J.H., Rosenberg M.E., Kupersmith M.J., Cohen H., Zagzag D., et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35 (1994) 1001-1010
3. Janzer R.C., Berger P.C., Giangaspero F., and Paulus W. In: Keihues P., and Cavenee W.K. (Eds). Tumors of the nervous system, pathology & genetics. World Health Organization classification of tumors. Chapter: tumors of the sellar region (2000), IARC Press, Lyon, France 244-246
4. Uematsu Y., Tanaka Y., Matsumoto H., Funahashi K., Itakura T., and Komai N. Histological analysis of craniopharyngiomas with special reference to their histological origin and differentiation. No To Shinkei 46 (1994) 271-276
5. Balzar M., Winter M.J., de Boer C.J., et al. The biology of the 17-IA antigen (EpCAM). J Mol Med 77 (1999) 699-712
6. Munz M., Kieu C., Mack B., Schmitt B., Zeidler R., and Gires O. The carcinoma associated antigen EpCAM up-regulates c-myc and induces cell proliferation. Oncogene 23 (2004) 5748-5758
7. Went P.T., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., et al. Frequent Ep-CAM protein expression in human carcinomas. Hum Pathol 35 (2004) 122-128
8. Piyathilake C.I., Frost A.R., Weiss H., et al. The expression of Ep-CAM in squamous cell cancer of the lung. Hum Pathol 31 (2000) 482-487
9. Osta W.A., Chen Y., Mikhitarian K., Mitas M., Salem M., Hannun Y.A., et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64 (2004) 5818-5824
10. Yu R., and Melmed S. Oncogene activation in pituitary tumors. Brain Pathol 11 (2001) 328-341
11. Yu R., and Melmed S. Pituitary tumor transforming gene: an update. Front Horm Res 32 (2004) 175-185
12. Musat M., Vax V.V., Borboli N., Gueorguiev M., Bonner S., Korbonits M., et al. Cell cycle dysregulation in pituitary oncogenesis. Front Horm Res 32 (2004) 34-62
13. Hamid T., and Kakar S.S. PTTG/securin activates expression of p53 and modulates its function. Mol Cancer 3 (2004) 18-23
14. Solbach C., Roller M., Fellbaum C., Nicoletti M., and Kaufmann M. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 13 (2004) 80-81
15. Mu Y.M., Oba K., Yanase T., Ito T., Ashida K., Goto K., et al. Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21 (WAF1/CIP1). Endocr J 50 (2003) 771-781
16. Nishimoto A., Matsuhisa T., Kunishio K., et al. Craniopharyngioma: early and long term recurrence after partial removal. J Neurol Neurosurg Psychiatry 58 (1995) 111-112
17. Kim S.K., Wang K.C., Shin S.H., et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Childs Nerv Syst 17 (2001) 531-536
18. Kristopaitis T., Thomas C., Petruzzelli G.J., and Lee J.M. Malignant craniopharyngioma. Arch Pathol Lab Med 124 (2000) 1356-1360
19. Petito C.K. Craniopharyngioma: prognostic importance of histologic features. AJNR Am J Neuroradiol 17 (1996) 1441-1442
20. Parate S.N., Anshu, Helwatkar S.B., and Munsh M.M. Cytology of recurrent ameloblastoma with malignant changes. Acta Cytol 43 (1999) 1105-1107
21. Sato K., Oka H., Utsuki S., Kondo K., Kurata A., and Fujii K. Ciliated craniopharyngioma may arise from Rathke cleft cyst. Clin Neuropathol 25 (2006) 25-28
22. Luse S.A., and Kernohan J.W. Squamous-cell nests of the pituitary gland. Cancer 8 (1955) 623-628
23. Asa S.L. Tumors of the pituitary gland. Atlas of tumors of pathology (2001), Armed Forces Institute of Pathology, Bethesda (Md) 167-176
24. Scheithauer B.W., Horvath E., Kovacs K., Lloyd R.V., Stefaneanu L., Buchfelder M., et al. Prolactin-producing pituitary adenoma and carcinoma with neuronal components a metaplastic lesion. Pituitary 1 (1999) 197-205
25. Renner U., Pagotto U., Arzt E., and Stalla G.K. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. Eur J Endocrinol 135 (1996) 515-532
26. Kato K., Nakatani Y., Kanno H., Inayama Y., Ijiri R., Nagahara N., et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203 (2004) 814-821
27. Izumoto S., Suzuki T., Kinoshita M., Hashiba T., Kagawa N., Wada K., et al. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features. Surg Neurol 63 (2005) 520-525
28. Tachibana O., Yamashima T., Yamashita J., and Takabatake Y. Immunohistochemical expression of human chorionic gonadotropin and P-glycoprotein in human pituitary glands and craniopharyngiomas. J Neurosurg 80 (1994) 79-84
29. Uchino Y., Saeki N., Iwadate Y., Yasuda T., Konda S., Watanabe T., et al. Recurrence of sellar and suprasellar tumors in children treated with hGH-relation to immunohistochemical study on GH receptor. Endocr J 47 (2000) 33-36